{"title": "Modeling and Prediction of the 2019 Coronavirus Disease Spreading in China Incorporating Human Migration Data", "doi": "10.1101/2020.02.18.20024570", "citation_id": "2020.02.18.20024570v1", "date": "2020-02-20", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.18.20024570", "abstract": "<p>This study integrates the daily intercity migration data with the classic Susceptible-Exposed-Infected-Removed (SEIR) model to construct a new model suitable for describing the dynamics of epidemic spreading of Coronavirus Disease 2019 (COVID-19) in China. Daily intercity migration data for 367 cities in China are collected from Baidu Migration, a mobile-app based human migration tracking data system. Historical data of infected, recovered and death cases from official source are used for model fitting. The set of model parameters obtained from best data fitting using a constrained nonlinear optimization procedure is used for estimation of the dynamics of epidemic spreading in the coming weeks. Our results show that the number of infections in most cities in China will peak between mid February to early March 2020, with about 0.8%, less than 0.1% and less than 0.01% of  the population eventually infected in Wuhan, Hubei Province and the rest of China, respectively.</p>", "twitter_description": "This study integrates the daily intercity migration data with the classic Susceptible-Exposed-Infected-Removed (SEIR) model to construct a new model suitable for describing the dynamics of epidemic spreading of Coronavirus Disease 2019 (COVID-19) in China. Daily intercity migration data for 367 cities in China are collected from Baidu Migration, a mobile-app based human migration tracking data system. Historical data of infected, recovered and death cases from official source are used for model fitting. The set of model parameters obtained from best data fitting using a constrained nonlinear optimization procedure is used for estimation of the dynamics of epidemic spreading in the coming weeks. Our results show that the number of infections in most cities in China will peak between mid February to early March 2020, with about 0.8%, less than 0.1% and less than 0.01% of the population eventually infected in Wuhan, Hubei Province and the rest of China, respectively.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNational Science Foundation of China Project 61703355, Guangdong Youth University Innovative Talents Project 2016KQNCX223, and City University of Hong Kong Special Fund 9380114.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nThe human migration data are obtained from Baidu Migration (link: http://qianxi.baidu.com), and the COVID-19 infection data for China are provided by National Health Commission of China and available from https://ncov.dxy.cn/ncovh5/view/pneumonia.\n\n<http://qianxi.baidu.com/>\n\n<https://ncov.dxy.cn/ncovh5/view/pneumonia>", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.18.20024570v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.18.20024570v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.18.20024570v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/20/2020.02.18.20024570.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at http://creativecommons.org/licenses/by-nc/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.18.20024570v1", "access_rights": "restricted", "authors": ["Choujun Zhan", "Chi K. Tse", "Yuxia Fu", "Zhikang Lai", "Haijun Zhang"]}